Medical device company NeoTract Inc. enrolled the first U.S. patients in a multinational trial of its treatment of benign prostatic hyperplasia, a prostate condition in men that eventually can block the urethra.
NeoTract, based in Pleasanton and started in 2004 in New Enterprise Associates’ ExploraMed incubator in Mountain View, said the 204-patient trial of its UroLift device will involve three months of actual treatment and will be completed in December 2012.
No comments:
Post a Comment